Content about Specialty pharmacy

March 17, 2010
FDA approves Carbaglu

The Food and Drug Administration has approved a drug for treating a condition that causes...

March 17, 2010
Merck, Portola release results of mid-stage betrixaban trial

An investigational pill reduced bleeding in patients with atrial fibrillation better than a widely available...

March 17, 2010
Pfizer presents efficacy data of Prevenar 13 at conference

A phase-3 clinical trial found that a pneumococcal disease vaccine was well-tolerated and immunogenic in...

March 17, 2010
Roche calls its R&D status 'uniquely positioned'

Roche leaders appear confident about their company’s research and development position, with several investigational drugs...

March 16, 2010
MiddleBrook expanding promotion of Moxatag through IncreaseRx program

MiddleBrook Pharmaceuticals plans to promote its extended-release antibiotic by expanding a Web-based marketing program, the...

March 16, 2010
The Medicines Co. recalls lots of Cleviprex

The Medicines Co. is expanding a voluntary recall of an injectable hypertension drug due to...

March 15, 2010
AssistMed, Definitive Homecare Solutions announce partnership

AssistMed and Definitive Homecare Solutions plan to make AssistMed’s patient adherence and disease-management software available...

March 15, 2010
Pharmacy students at University of Rhode Island to perform community service

The University of Rhode Island’s pharmacy program is requiring students to do community service, according...

March 14, 2010
FDA approves Eisai's Dacogen

The Food and Drug Administration has approved a five-day dosing regimen for an injectable drug...

March 11, 2010
Abbott's submits supplemental approval application for Lupron Depot to FDA

Abbott is hoping that the Food and Drug Administration will approve one of its drugs...

March 11, 2010
Caraco launches colon, rectal cancer generic

Caraco Pharmaceutical Labs has launched a generic version of a drug for treating colon and...

March 11, 2010
FDA seeks to establish link between thigh-bone fractures, bisphosphonates

Analysis by the Food and Drug Administration has yet to establish a link between thigh-bone...

March 11, 2010
Late-stage clinical trial of Avastin fails to meet expectations, Genentech says

A late-stage clinical trial of a Genentech drug for men with late-stage prostate cancer has...

March 11, 2010
Pfizer says clinical trials for Sutent did not meet expectations; halts additional cancer treatment study

Two clinical trials of a Pfizer drug for treating advanced breast cancer have failed, Pfizer...

March 11, 2010
Watson gets FDA approval for Trelstar

The Food and Drug Administration has approved a Watson Pharmaceuticals drug for treating cancer, Watson...

March 10, 2010
Bayer receives orphan drug designation for CF treatment

The Food and Drug Administration has given orphan drug designation to an investigational treatment for...

March 10, 2010
FDA accepts approval application for lurasidone

The Food and Drug Administration has accepted an approval application for a new drug to...

March 10, 2010
Study finds Vimpat 'significantly' reduces partial-onset seizures

An investigational drug can reduce seizures in adolescents and adults with epilepsy when added on...

March 9, 2010
Abbott to boost business with Facet acquisition

Abbott will acquire Facet Biotech for $450 million, the drug maker announced Wednesday....

March 9, 2010
Decision Resources: Acute migraine therapy designed for vascular disease patients will capture market share

A company that develops a drug for acute migraines in pill form that doesn’t interact...

March 9, 2010
FDA committee recommends approval for InterMune’s Esbriet

A Food and Drug Administration committee has recommended approval for an investigational drug for treating...

March 7, 2010
Bristol-Myers Squibb, Isis announce partnership for cholesterol drug

Bristol-Myers Squibb has paid Isis Pharmaceuticals a $6 million milestone payment for regulatory approval to...

March 7, 2010
Clinical study: Pfizer-Bristol anticoagulant more effective than competitior

A pill-based anticoagulant drug under development by Pfizer and Bristol-Myers Squibb worked better in reducing...

March 7, 2010
Genzyme, PTC: Mid-stage trial for DBMD treatment yields mixed results

A mid-stage clinical trial of a drug for muscular dystrophy got mixed results, developers Genzyme...

March 7, 2010
Roche, Biogen Idec halt ocrelizumab trials

Roche and Biogen Idec are suspending trials of a drug for treating autoimmune disorders amid...

© 2013 Drug Store News. All Rights Reserved.